Sia TY, Manning-Geist BL, Ehmann S, Lavery JA, et al. Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study. Gynecol Oncol 2023;176:69-75.
PMID: 37454565